» Articles » PMID: 28810146

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets

Abstract

Blood-based liquid biopsies, including tumor-educated blood platelets (TEPs), have emerged as promising biomarker sources for non-invasive detection of cancer. Here we demonstrate that particle-swarm optimization (PSO)-enhanced algorithms enable efficient selection of RNA biomarker panels from platelet RNA-sequencing libraries (n = 779). This resulted in accurate TEP-based detection of early- and late-stage non-small-cell lung cancer (n = 518 late-stage validation cohort, accuracy, 88%; AUC, 0.94; 95% CI, 0.92-0.96; p < 0.001; n = 106 early-stage validation cohort, accuracy, 81%; AUC, 0.89; 95% CI, 0.83-0.95; p < 0.001), independent of age of the individuals, smoking habits, whole-blood storage time, and various inflammatory conditions. PSO enabled selection of gene panels to diagnose cancer from TEPs, suggesting that swarm intelligence may also benefit the optimization of diagnostics readout of other liquid biopsy biosources.

Citing Articles

Liquid biopsy into the clinics: Current evidence and future perspectives.

Boukovala M, Westphalen C, Probst V J Liq Biopsy. 2025; 4:100146.

PMID: 40027149 PMC: 11863819. DOI: 10.1016/j.jlb.2024.100146.


Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. "Re-discovering the neglected biosources of the liquid biopsy family".

Gottardo A, Gristina V, Perez A, Di Giovanni E, Contino S, Barraco N J Liq Biopsy. 2025; 3:100136.

PMID: 40026563 PMC: 11863699. DOI: 10.1016/j.jlb.2024.100136.


Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study.

Ohara S, Suda K, Sudhaman S, Hamada A, Chiba M, Shimoji M JTO Clin Res Rep. 2025; 6(3):100762.

PMID: 39990137 PMC: 11847260. DOI: 10.1016/j.jtocrr.2024.100762.


The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy.

Morales-Pacheco M, Valenzuela-Mayen M, Gonzalez-Alatriste A, Mendoza-Almanza G, Cortes-Ramirez S, Losada-Garcia A Biomark Res. 2025; 13(1):27.

PMID: 39934930 PMC: 11818056. DOI: 10.1186/s40364-025-00742-w.


Development of an accurate breast cancer detection classifier based on platelet RNA.

Xie W, Hu J, Zhao Z, Lu H, Han Y, Li B Sci Rep. 2024; 14(1):30733.

PMID: 39730431 PMC: 11680589. DOI: 10.1038/s41598-024-80175-x.


References
1.
J van t Veer L, Dai H, van de Vijver M, He Y, Hart A, Mao M . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-6. DOI: 10.1038/415530a. View

2.
Denis M, Tolley N, Bunting M, Schwertz H, Jiang H, Lindemann S . Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005; 122(3):379-91. PMC: 4401993. DOI: 10.1016/j.cell.2005.06.015. View

3.
Dittrich M, Birschmann I, Pfrang J, Herterich S, Smolenski A, Walter U . Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost. 2006; 95(4):643-51. View

4.
Schwertz H, Tolley N, Foulks J, Denis M, Risenmay B, Buerke M . Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006; 203(11):2433-40. PMC: 2118136. DOI: 10.1084/jem.20061302. View

5.
Dymicka-Piekarska V, Kemona H . Thrombopoietin and reticulated platelets as thrombopoietic markers in colorectal cancer. Thromb Res. 2007; 122(1):141-3. DOI: 10.1016/j.thromres.2007.10.003. View